Express Pharma
Express Pharma
Browsing tag
Eli Lilly
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
Read more
Lilly’s pancreatic cancer treatment fails late-stage study
Read more
Lilly’s targeted RET drug shrinks tumours in lung cancer trial
Read more
China expands drug bulk-buy programme, puts pressure on pharma firms
Read more
Posts navigation
Previous
Page 1 of 6
…
Page 6 of 6